Immediate Impact

1 by Nobel laureates 55 standout
Sub-graph 1 of 24

Citing Papers

Latest advances in hepatocellular carcinoma management and prevention through advanced technologies
2024 Standout
Exploiting senescence for the treatment of cancer
2022 Standout
2 intermediate papers

Works of Silvia Comis being referenced

A Phase I Dose-Escalation Study of Danusertib (PHA-739358) Administered as a 24-Hour Infusion with and without Granulocyte Colony-Stimulating Factor in a 14-Day Cycle in Patients with Advanced Solid Tumors
2009
Randomized open study of the dose-effect relationship of a short course of IdB 1016 in patients with viral or alcoholic hepatitis
1993

Author Peers

Author Last Decade Papers Cites
Silvia Comis 206 122 51 84 21 361
Young Hye Ko 130 106 36 32 20 339
Hiroyuki Tsuruta 192 164 15 18 18 395
B Diouf 91 164 62 15 21 359
Greenspan Em 154 68 33 19 23 397
Samira Syed 148 120 44 25 35 381
I. Sklenar 94 131 92 33 23 371
Jae Hong Seo 160 179 17 16 16 386
Mellett Lb 129 111 31 11 13 311
Yang Ym 52 116 42 68 22 313
Jennifer Rauw 119 232 34 88 14 392

All Works

Loading papers...

Rankless by CCL
2026